Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, D.
Right arrow Articles by Yankee, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, D.
Right arrow Articles by Yankee, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Nonfatal graft-versus-host disease occurring after transfusion with leukocytes and platelets obtained from normal donors

D Cohen, H Weinstein, M Mihm and R Yankee

There have been two previous reports of fatal graft-versus-host (GVH) disease following transfusion of leukocytes from normal donors for the supportive care of leukemic patients. We have reported a nonfatal case of GVH disease in a child with acute monoblastic leukemia who received leukocyte and platelet transfusions from normal donors. The dose of lymphocytes contained in both leukocyte and platelet concentrates obtained with a semicontinuous-flow cell separator is sufficient to cause GVH disease. Irradiation of all blood products administered to severely immunocompromised and myelosuppressed patients should be considered.

Volume 53, Issue 6, pp. 1053-1057, 06/01/1979
Copyright © 1979 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
B. J. Spellberg, M. Collins, V. Avanesian, M. Gomez, J. E. Edwards Jr., C. Cogle, D. Applebaum, Y. Fu, and A. S. Ibrahim
Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts
J. Leukoc. Biol., March 1, 2007; 81(3): 632 - 641.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
B. J. Spellberg, M. Collins, S. W. French, J. E. Edwards Jr, Y. Fu, and A. S. Ibrahim
A phagocytic cell line markedly improves survival of infected neutropenic mice
J. Leukoc. Biol., August 1, 2005; 78(2): 338 - 344.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
S. D. Decoste, C. Boudreaux, and J. S. Dover
Transfusion-Associated Graft-vs-Host Disease in Patients With Malignancies: Report of Two Cases and Review of the Literature
Arch Dermatol, October 1, 1990; 126(10): 1324 - 1329.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
P. Weiden
Graft-v-Host Disease Following Blood Transfusions
Arch Intern Med, August 1, 1984; 144(8): 1557 - 1558.
[Abstract] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1979 by American Society of Hematology         Online ISSN: 1528-0020